Vandana Singh
·
September 2, 2025
Benzinga
Novo Nordisk's Wegovy cut cardiovascular risks significantly versus tirzepatide in a real-world study, showing fewer heart attacks, strokes, and deaths.
read more
November 8, 2025
September 5, 2025
Barchart
Financial Times
August 20, 2025
Bloomberg